![Johnny Stilou](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Johnny Stilou
Financieel Directeur/CFO bij SCANDION ONCOLOGY A/S
Profiel
Johnny Stilou is currently the Chief Financial Officer at Scandion Oncology A.
Prior to his current position, he held various CFO roles at Veloxis Pharmaceuticals A, Nuevolution AB, Fritz Schur Technical Group A, Silicon Labs Denmark, and Amgen Research (Munich) GmbH.
Mr. Stilou obtained a graduate degree from Copenhagen Business School.
Actieve functies van Johnny Stilou
Bedrijven | Functie | Begin |
---|---|---|
SCANDION ONCOLOGY A/S | Financieel Directeur/CFO | 01-08-2021 |
Eerdere bekende functies van Johnny Stilou
Bedrijven | Functie | Einde |
---|---|---|
NUEVOLUTION AB (PUBL) | Financieel Directeur/CFO | 01-08-2021 |
Fritz Schur Technical Group A/S
![]() Fritz Schur Technical Group A/S Wholesale DistributorsDistribution Services Part of FS 12 ApS, Fritz Schur Technical Group A/S is a Danish company that supplies industrial equipment. The company is based in Albertslund, Denmark. The CEO of the company is Mads-Ole Astrupgaard. | Financieel Directeur/CFO | 01-01-2018 |
VELOXIS PHARMACEUTICALS A/S | Financieel Directeur/CFO | 01-08-2016 |
Silicon Labs Denmark | Financieel Directeur/CFO | 01-01-2007 |
Amgen Research (Munich) GmbH
![]() Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Part of Amgen, Inc., Amgen Research (Munich) GmbH is a biotechnology company based in Munich, Germany. The company has over 850 employees working at two locations in Germany. Amgen Scholars Europe Programs offer practical research experience to 100 students from all over Europe every summer. The company utilizes biotechnological possibilities to develop innovative treatments for diseases. The company continuously develops new substances to provide biopharmaceuticals to patients worldwide with serious illnesses. The CEOs of the company are Peter Kufer and Robert Saller. Amgen Research (Munich was acquired by ECKA Granulate GmbH & Co. KG from Aurubis AG on June 13, 2002. | Financieel Directeur/CFO | - |
Opleiding van Johnny Stilou
Copenhagen Business School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SCANDION ONCOLOGY A/S | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Veloxis Pharmaceuticals A/S
![]() Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
Amgen Research (Munich) GmbH
![]() Amgen Research (Munich) GmbH Metal FabricationProducer Manufacturing Part of Amgen, Inc., Amgen Research (Munich) GmbH is a biotechnology company based in Munich, Germany. The company has over 850 employees working at two locations in Germany. Amgen Scholars Europe Programs offer practical research experience to 100 students from all over Europe every summer. The company utilizes biotechnological possibilities to develop innovative treatments for diseases. The company continuously develops new substances to provide biopharmaceuticals to patients worldwide with serious illnesses. The CEOs of the company are Peter Kufer and Robert Saller. Amgen Research (Munich was acquired by ECKA Granulate GmbH & Co. KG from Aurubis AG on June 13, 2002. | Producer Manufacturing |
Zensys, Inc.
![]() Zensys, Inc. Computer CommunicationsElectronic Technology Zensys, Inc. provides wireless communication services. It offers Z-Wave technology, a radio frequency-based mesh network and communications protocol, which enables everyday devices to be controlled & monitored wirelessly. The company also provides control & status reading application services for residential, energy management, access control, security and building automation. Zensys was founded in 2000 and is headquartered in Fremont, CA. | Electronic Technology |
Nuevolution AB
![]() Nuevolution AB Pharmaceuticals: MajorHealth Technology Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark. | Health Technology |
Silicon Labs Denmark | |
Fritz Schur Technical Group A/S
![]() Fritz Schur Technical Group A/S Wholesale DistributorsDistribution Services Part of FS 12 ApS, Fritz Schur Technical Group A/S is a Danish company that supplies industrial equipment. The company is based in Albertslund, Denmark. The CEO of the company is Mads-Ole Astrupgaard. | Distribution Services |